New study tests Same-Day treatment for Cone-Shaped corneas

NCT ID NCT07629557

Recruiting now Disease control Sponsor: Glaukos Corporation Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether it is safe and possible to perform corneal cross-linking on both eyes on the same day in people with keratoconus, a condition where the cornea thins and bulges. Fifteen participants will receive riboflavin eye drops and UV-A light treatment in both eyes at one visit. The goal is to see if the procedure can be completed successfully without major issues.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Riboflavin eye drops and UV-A light
What this could lead to: If successful, this could allow people with keratoconus to have both eyes treated on the same day, making the procedure more convenient.
What could go wrong: This is a very small early feasibility study with only 15 participants, so results may not apply to everyone. The procedure also carries risks like infection or corneal scarring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

keratoconus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KERATOCONUS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Glaukos Investigative Site
RECRUITING

Westerville, Ohio, 43082, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.